FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved Oceanside Pharmaceuticals' supplemental application for diclofenac sodium (a generic NSAID).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• DICLOFENAC SODIUM (DICLOFENAC SODIUM)

Snippet

SUPPL AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM)